Meeting to be held in the Mid-Atlantic area 4/15, in New York on April 16 and in Boston on April 17 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCM:
- IceCure Medical management to meet with Oppenheimer
- Icecure Medical in Jeopardy: Navigating Nasdaq Delisting Risks and Future Uncertainties
- IceCure Medical’s Sales Surge as FDA Review Looms
- IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense® and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast Cancer Study Data to FDA this Month for Marketing Clearance
- IceCure Seeks FDA Nod for Advanced Cryoablation Device